Clinical and Microbiological Study of Enduracidin in Infections Due to Methicillin-Resistant Strains of Staphylococcus aureus

Autor:	Elisabeth Schoutens, M. Peromet, Eugène Yourassowsky
Rok vydání:	1973
Předmět:	Pharmacology business.industry Urinary system General Medicine medicine.disease_cause Staphylococcal infections medicine.disease Microbiology Infectious Diseases Oncology Staphylococcus aureus Drug Discovery medicine Pharmacology (medical) business
Zdroj:	Chemotherapy. 19:53-61
ISSN:	1421-9794 0009-3157
DOI:	10.1159/000221439
Popis:	Enduracidin, administered in doses of 100 mg i.m. every 12 hours for about 10 days, to 20 patients suffering from infections due to methicillin-resistant strains of Staphylococcus aureus, eliminated the microorganism in 8 cases of urinary tract infections, in 4 out of 9 cases of dermatological infections, and in none of 3 cases of chronic osseous infections. No toxic phenomenon or side-effect was observed. No increased resistance of the strains was noted in course of treatment. The blood levels, of the order of 0.5 μg/ml, 2 and 6 h after the first injection, were higher at the end of treatment (2–3 μg/ml), bearing witness to an accumulation phenomenon. The bactericidal activity of the patients’ sera is directly related to their enduracidin level.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::69f8941199723113ae77f52b2c44d820 https://doi.org/10.1159/000221439 Zobrazit plný text záznamu